Literature DB >> 7906497

Human type I and II IMP dehydrogenases as drug targets.

Y Natsumeda1, S F Carr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906497     DOI: 10.1111/j.1749-6632.1993.tb17144.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

Review 1.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Pharmacological targeting of allergen-specific T lymphocytes.

Authors:  Peter A Tauber; Winfried F Pickl
Journal:  Immunol Lett       Date:  2017-03-18       Impact factor: 3.685

3.  IMP dehydrogenase from Pneumocystis carinii as a potential drug target.

Authors:  M J O'Gara; C H Lee; G A Weinberg; J M Nott; S F Queener
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.

Authors:  Y Liu; S A Bohn; J L Sherley
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

5.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

Authors:  M Colic; Z Stojic-Vukanic; B Pavlovic; D Jandric; I Stefanoska
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.

Authors:  Sofie Haglund; Jan Taipalensuu; Curt Peterson; Sven Almer
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

7.  Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.

Authors:  Jörg Fellenberg; Pierre Kunz; Heiner Sähr; Daniela Depeweg
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

8.  Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment.

Authors:  Barbara G Fürnrohr; Benjamin Rhodes; Luis E Munoz; Katrin Weiß; Tim J Vyse; Georg Schett
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

9.  In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes.

Authors:  Maciej Guzera; Lidia Szulc-Dąbrowska; Anna Cywińska; Joy Archer; Anna Winnicka
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

10.  Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.

Authors:  Venkat Reddy; Lina Martinez; David A Isenberg; Maria J Leandro; Geraldine Cambridge
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.